| pubmed-article:6134774 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6134774 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:6134774 | lifeskim:mentions | umls-concept:C0021756 | lld:lifeskim |
| pubmed-article:6134774 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:6134774 | lifeskim:mentions | umls-concept:C1511636 | lld:lifeskim |
| pubmed-article:6134774 | lifeskim:mentions | umls-concept:C1998793 | lld:lifeskim |
| pubmed-article:6134774 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:6134774 | lifeskim:mentions | umls-concept:C1709634 | lld:lifeskim |
| pubmed-article:6134774 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6134774 | pubmed:dateCreated | 1983-8-26 | lld:pubmed |
| pubmed-article:6134774 | pubmed:abstractText | Precursors of cytotoxic lymphoid cells obtained from mice treated with cyclophosphamide (CY) can be expanded in culture by alloantigens in the presence of purified human interleukin 2 (IL 2). Similarly, IL 2 delivered in vivo in a rate-controlled manner enhances cytotoxic activity in mice that are immunosuppressed by high doses of CY. The effector cells are Thy-1.2+ and are not elicited in the absence of antigen. | lld:pubmed |
| pubmed-article:6134774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6134774 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6134774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6134774 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6134774 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6134774 | pubmed:issn | 0022-1767 | lld:pubmed |
| pubmed-article:6134774 | pubmed:author | pubmed-author:MerluzziV JVJ | lld:pubmed |
| pubmed-article:6134774 | pubmed:author | pubmed-author:MertelsmannRR | lld:pubmed |
| pubmed-article:6134774 | pubmed:author | pubmed-author:WelteKK | lld:pubmed |
| pubmed-article:6134774 | pubmed:author | pubmed-author:Last-BarneyKK | lld:pubmed |
| pubmed-article:6134774 | pubmed:author | pubmed-author:SavageD MDM | lld:pubmed |
| pubmed-article:6134774 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6134774 | pubmed:volume | 131 | lld:pubmed |
| pubmed-article:6134774 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6134774 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6134774 | pubmed:pagination | 806-9 | lld:pubmed |
| pubmed-article:6134774 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:meshHeading | pubmed-meshheading:6134774-... | lld:pubmed |
| pubmed-article:6134774 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6134774 | pubmed:articleTitle | Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2. | lld:pubmed |
| pubmed-article:6134774 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6134774 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6134774 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6134774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6134774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6134774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6134774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6134774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6134774 | lld:pubmed |
